Two weeks after the European Medicines Agency first assured EU member states it had found no link between the Oxford/AstraZeneca vaccine and earlier reports of rare blood clots, a growing number of countries have announced new restrictions on the use of the jab.
兩周前，歐洲藥品管理局(European Medicines Agency)首次向歐盟成員國(guó)保證，它沒(méi)有發(fā)現(xiàn)牛津/阿斯利康(Oxford/AstraZeneca)疫苗與早些時(shí)候報(bào)告的罕見(jiàn)血栓病例存在聯(lián)系，而現(xiàn)在已有越來(lái)越多的國(guó)家宣布限制接種該疫苗。
您已閱讀4%（386字），剩余96%（9573字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專(zhuān)屬服務(wù)。